Notable Labs (NASDAQ:NTBL) Stock Rating Lowered by JMP Securities

Notable Labs (NASDAQ:NTBL) was downgraded by equities researchers at JMP Securities from an “outperform” rating to a “market perform” rating in a research note issued to investors on Friday, Marketbeat Ratings reports.

Notable Labs Stock Up 5.5 %

Notable Labs stock opened at $0.48 on Friday. The stock’s fifty day moving average is $0.57 and its two-hundred day moving average is $0.91. Notable Labs has a 1-year low of $0.45 and a 1-year high of $10.08. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.77 and a current ratio of 2.77.

Notable Labs (NASDAQ:NTBL) last released its earnings results on Wednesday, August 14th. The company reported ($0.55) earnings per share (EPS) for the quarter. On average, equities research analysts anticipate that Notable Labs will post -0.75 EPS for the current fiscal year.

Notable Labs Company Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.